UNSPSC 85841106: Osteopathic treatment of upper extremities using indirect forces

This classification denotes the group of activities that yields a osteopathic intervention or procedure to treatment of upper extremities using indirect forces. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 7W07X4Z

UNSPSC 85841106 Osteopathic treatment of upper extremities using indirect forces is a Commodity code that shows no recent state and local procurement activity aligned with its nominal scope. The five recent opportunities posted under this code since February 2026 span inmate medical and pharmacy services, pharmacy benefit management, virtual primary and urgent care, peer support for peer workers, and fire department medical direction—none of which involve osteopathic manipulation or upper-extremity treatment. The code appears to be a mismatch for the work actually being solicited, suggesting either a classification error in the source data or that state and local procurement offices are tagging broadly defined healthcare contracts with a narrowly specific clinical-services code without regard to actual service lines being purchased.

The recent opportunities instead reflect state and local governments' ongoing procurement of comprehensive healthcare administration, mental health services, and medical direction across counties in Georgia, Florida, and California. The Columbus Consolidated Government (Muscogee County, Georgia) issued an RFP due May 15, 2026, for inmate medical and pharmacy services; Collier County, Florida, issued an RFP due April 9, 2026, for pharmacy benefit management covering 2,400 enrolled employees; Monroe County, Florida, issued an RFP due April 16, 2026, for virtual primary and urgent care services; and Santa Monica, California, issued an RFP due October 16, 2025, for a fire department medical director. If your firm pursues this code, verify the actual UNSPSC classification with the issuing body before investing in proposal development, as the nominal code does not align with the healthcare administration and clinical oversight work that procurement offices are currently buying under it.